Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function

Molecular Endocrinology

Volumn 15, Issue 1, 2001, Pages 46-56

  Buchanan, Grant ^a   Yang, Miao ^a   Harris, Jonathan M ^b   Nahm, Hyun S ^c   Han, Guangzhou ^c   Moore, Nicole ^a   Bentel, Jacqueline M ^a   Matusik, Robert J ^d   Horsfall, David J ^a   Marshall, Villis R ^a   Greenberg, Norman M ^c   Tilley, Wayne D ^a,e  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d VANDERBILT INGRAM CANCER CENTER   (United States)

^e FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANDROGEN RECEPTOR; ANDROSTANOLONE; ESTRADIOL; HYDROXYFLUTAMIDE; PROGESTERONE; RECEPTOR ANTIBODY; RECEPTOR PROTEIN; STEROID RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA BINDING; GENE MUTATION; HUMAN; HUMAN CELL; HYDROPHOBICITY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN PROTEIN INTERACTION; RECEPTOR INTRINSIC ACTIVITY;

ANIMALIA;

EID: 17744378148     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.15.1.0581     Document Type: Article

References (61)

1. The steroid receptor superfamily: More excitement predicted for the future
2. Genetic regulation of androgen action
3. Nuclear receptor coactivators
4. Co-activators and co-repressors in the integration of transcriptional responses
5. Androgen receptor defects: Historical, clinical, and molecular perspectives
6. Androgen receptor mutations in prostare cancer
7. Mutation of the androgen-receptor gene in metastatic androgen- independent prostate cancer
8. Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence
9. Androgen receptors in prostare cancer
10. A mutation in the ligand binding domain of the androgen receptor of human LN-CaP cells affects steroid binding characteristics and response to anti-androgens
11. Dehydroepi-androsterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells
12. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone
13. Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor
14. Structural evidence for ligand specificity in the binding domain of the human Androgen receptor: Implications for pathogenic gene mutations
15. Update of the androgen receptor gene mutations database
16. A transgenic mouse prostate cancer model
17. Androgen-independent prostate cancer progression in the TRAMP model
18. Atomic structure of progesterone complexed with its receptor
19. Androgen resistance associated with a mutation of the androgen receptor at amino acid 772 (Arg - Cys) results from a combination of decreased messenger ribonucleic acid levels and impairment of receptor function
20. The androgen-specific probasin response element 2 interacts differentially with androgen and glucocorticoid receptors
21. Antipeptide antibodies to two distinct regions of the androgen receptor localize the receptor protein to the nuclei of target cells in the rat and human prostate
22. Increasing the complexity of coactivation in nuclear receptor signaling
23. Nuclear receptor coactivators and corepressors
24. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors
25. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
26. AIB1, a steroid receptor coactivator amplifled in breast and ovarian cancer
27. A signature motif in transcriptional co-activators mediates binding to nuclear receptors
28. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC- 1): Multiple motifs with different binding specificities
29. Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists
30. Interaction of a transcriptional coactivator with normal and mutant androgen receptors
31. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors
32. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
33. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α
34. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor
35. The presence of a transcription activation function in the hormone- binding domain of androgen receptor is revealed by studies in yeast cells
36. Ligand-induced conformational alterations of the androgen receptor analyzed by limited trypsinization. Studies on the mechanism of antiandrogen action
37. Ubc9 interacts with the androgen receptor and activates receptor- dependent transcription
38. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor corepressor
39. A transcriptional co-repressor that interacts with nuclear hormone receptors
40. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors
41. Mechanism of corepressor binding and release from nuclear hormone receptors
42. Molecular determinants of nuclear receptor-corepressor interaction
43. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT
44. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen
45. Androgen receptor gene expression in human prostate carcinoma cell lines
46. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms
47. Mutations of p53 gene and their relation to disease progression in B-cell lymphoma
48. Characterization and expression of a cDNA encoding the human androgen receptor
49. The "megaprimer" method of site-directed mutagenesis
50. Selective activation of the probasin androgen-responsive region by steroid hormones
51. GRIP1, a transcriptional coactivator for the AF-2 trans-activation domain of steroid, thyroid, retinoid, and vitamin D receptors
52. Androgen resistance associated with a qualitative abnormality of the androgen receptor and responsive to high dose androgen therapy
53. Androgen receptors in endocrine-therapy-resistant human prostate cancer
54. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
55. Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter
56. Sculpting proteins interactively: Continual energy minimization embedded in a graphical modeling system
57. Three-dimensional quantitative similarity-activity relationships (3D QSiAR) from SEAL similarity matrices
58. Optimal protocol and trajectory visualization for conformational searches of peptides and proteins
59. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures
60. Raster3D Version 2.0. A program for photorealistic molecular graphics